Fortress Biotech, Inc. (NASDAQ:FBIOP) Short Interest Up 97.9% in April

Fortress Biotech, Inc. (NASDAQ:FBIOP) saw a large increase in short interest in the month of April. As of April 15th, there was short interest totalling 9,500 shares, an increase of 97.9% from the March 31st total of 4,800 shares. Based on an average trading volume of 12,800 shares, the short-interest ratio is currently 0.7 days.

Fortress Biotech Price Performance

FBIOP stock traded up $0.52 during trading on Friday, reaching $13.82. 4,596 shares of the company were exchanged, compared to its average volume of 13,002. The company has a 50-day moving average of $15.90 and a two-hundred day moving average of $13.56. Fortress Biotech has a twelve month low of $6.40 and a twelve month high of $18.91.

Fortress Biotech Dividend Announcement

The business also recently disclosed a monthly dividend, which will be paid on Tuesday, April 30th. Investors of record on Monday, April 15th will be given a dividend of $0.1953 per share. This represents a $2.34 dividend on an annualized basis and a yield of 16.96%. The ex-dividend date is Friday, April 12th.

About Fortress Biotech

Fortress Biotech, Inc, a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino an oral minocycline drug for the treatment of moderate to severe acne; Targadox an oral doxycycline drug for adjunctive therapy for severe acne; Exelderm cream for antifungal intended for topical use; Qbrexza a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Amzeeq; Zilxi; and Accutane capsules for severe recalcitrant nodular acne.